Joseph Shulman

Direttore Tecnico/Scientifico/R&S presso RHYTHM PHARMACEUTICALS, INC.

Patrimonio netto: 1 232 $ in data 30/06/2024

49 anni

Health Technology

Consumer Services

Posizioni attive di Joseph Shulman

Società	Posizione	Inizio	Fine
RHYTHM PHARMACEUTICALS, INC.	Direttore Tecnico/Scientifico/R&S	27/07/2020	-

Società	Posizione	Inizio	Fine
RA PHARMACEUTICALS, INC.	Direttore Tecnico/Scientifico/R&S	01/07/2019	01/07/2020
NOVELION THERAPEUTICS INC.	Direttore Tecnico/Scientifico/R&S	01/09/2014	01/07/2019

Boston University	Masters Business Admin
University of Miami	Undergraduate Degree

Distribuzione geografica

Stati Uniti	5
Canada	2

Posizioni

Settori

Health Technology	4
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
RHYTHM PHARMACEUTICALS, INC.	Health Technology

Aziende private	2
Ra Pharmaceuticals, Inc. Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA.	Health Technology
Novelion Therapeutics, Inc. Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada.	Health Technology

Aziende private

Health Technology